{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:20:40Z","timestamp":1648966840647},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nrl.2016.02.013","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T18:30:14Z","timestamp":1460831414000},"page":"440-445","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Estudio comparativo de los niveles plasm\u00e1ticos de homociste\u00edna, vitamina B12 y \u00e1cido f\u00f3lico en pacientes epil\u00e9pticos frente a controles"],"prefix":"10.1016","volume":"32","author":[{"given":"L.","family":"Pulido Fontes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pulido Fontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Quesada Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Muruzabal P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mendioroz Iriarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2016.02.013_bib0130","first-page":"548","article-title":"Feen report on epilepsy in Spain","volume":"26","author":"Garcia-Ramos","year":"2011","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2016.02.013_bib0135","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nrl.2016.02.013_bib0140","first-page":"481","article-title":"Consensus-recommended diagnostic and therapeutic guidelines for drug-resistant epilepsy in Spain (Consenso RATE-Espana)","volume":"27","author":"Sanchez-Alvarez","year":"2012","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2016.02.013_bib0145","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2073","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: A nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.nrl.2016.02.013_bib0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0955-2863(90)90070-2","article-title":"Methionine metabolism in mammals","volume":"1","author":"Finkelstein","year":"1990","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nrl.2016.02.013_bib0155","first-page":"211","article-title":"Homocysteine. The cardiovascular risk factor of the next millennium?","volume":"18","author":"Suarez Garcia","year":"2001","journal-title":"An Med Interna"},{"key":"10.1016\/j.nrl.2016.02.013_bib0160","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.nrl.2016.02.013_bib0165","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2016.02.013_bib0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.99.1.178","article-title":"Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association","volume":"99","author":"Malinow","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.nrl.2016.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1515\/CCLM.2003.214","article-title":"DACH-LIGA homocystein (german, austrian and swiss homocysteine society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: Guidelines and recommendations","volume":"41","author":"Stanger","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nrl.2016.02.013_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(88)90023-X","article-title":"Experimental secondarily generalized convulsive status epilepticus induced by D, L-homocysteine thiolactone","volume":"2","author":"Walton","year":"1988","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nrl.2016.02.013_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12017-009-8110-1","article-title":"Homocysteine potentiates seizures and cell loss induced by pilocarpine treatment","volume":"12","author":"Baldelli","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.nrl.2016.02.013_bib0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0026-0495(97)90087-1","article-title":"Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants","volume":"46","author":"Ono","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.nrl.2016.02.013_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(96)00256-0","article-title":"Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy","volume":"145","author":"Kishi","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2016.02.013_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2012.07.003","article-title":"Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy","volume":"102","author":"Belcastro","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nrl.2016.02.013_bib0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.seizure.2012.01.013","article-title":"The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid","volume":"21","author":"Bochynska","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.nrl.2016.02.013_bib0210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.22229","article-title":"Antiepileptic drugs interact with folate and vitamin B12 serum levels","volume":"69","author":"Linnebank","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2016.02.013_bib0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2012.04.132","article-title":"B-vitamin deficiency in patients treated with antiepileptic drugs","volume":"24","author":"Mintzer","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.nrl.2016.02.013_bib0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2016.02.013_bib0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2016.02.013_bib0230","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1528-1167.2009.02303.x","article-title":"Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs","volume":"51","author":"Belcastro","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nrl.2016.02.013_bib0235","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/cclm-2012-0580","article-title":"Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism","volume":"51","author":"Semmler","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nrl.2016.02.013_bib0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2005.11.002","article-title":"Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6","volume":"15","author":"Sener","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.nrl.2016.02.013_bib0245","first-page":"521","article-title":"[Hyperhomocysteinemia and treatment with antiepileptic drugs. Effects of different doses of folic acid]","volume":"124","author":"Fernandez-Miranda","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.nrl.2016.02.013_bib0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-1211(02)00153-5","article-title":"The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs","volume":"51","author":"Apeland","year":"2002","journal-title":"Epilepsy Res"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T09:23:51Z","timestamp":1536830631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485316001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0213485316001225"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2016.02.013","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estudio comparativo de los niveles plasm\u00e1ticos de homociste\u00edna, vitamina B12 y \u00e1cido f\u00f3lico en pacientes epil\u00e9pticos frente a controles","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2016.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}